Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Previously submitted to: JMIR Formative Research (no longer under consideration since Aug 23, 2021)

Date Submitted: Aug 18, 2020

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Collecting patient reported outcomes to facilitate prescription opioid management: Development and testing of the Opioid Management App (OM-App)

  • Jessica Robinson-Papp; 
  • Gabriela Cedillo; 
  • Richa Deshpande; 
  • Mary Catherine George; 
  • Qiuchen Yang; 
  • Jason Rogers; 
  • Alexandra Nmashie; 
  • Bridget R. Mueller; 
  • Ashish Atreja; 
  • Benjamin Kummer; 
  • Emma K.T. Benn

ABSTRACT

Background:

Collecting patient-reported data needed by clinicians to adhere to opioid prescribing guidelines represents a significant time burden.

Objective:

We developed and tested an opioid management app (OM-App) to collect these data directly from patients.

Methods:

OM-App used a pre-existing digital health platform to deliver daily questions to patients via text-message and organize responses into a dashboard. We pilot tested OM-App over 9 months in 40 diverse participants with HIV who were prescribed opioids for chronic pain. Feasibility outcomes included: ability to export/integrate OM-App data with other research data; patient-reported barriers and adherence to OM-App use; capture of opioid-related harms, risk behaviors and pain intensity/interference; comparison of OM-App data to urine drug testing, prescription drug monitoring program data, and validated questionnaires.

Results:

OM-App data was exported/integrated into the research database after minor modifications. Thirty-nine of 40 participants were able to use OM-App, and over the study duration 70% of all OM-App questions were answered. Although the cross-sectional prevalence of opioid-related harms and risk behaviors reported via OM-App was low, some of these were not obtained via the other measures, and over the study duration all queried harms/risks were reported at least once via OM-App. Clinically meaningful changes in pain intensity/interference were captured.

Conclusions:

OM-App was used by our diverse patient population to produce clinically relevant opioid- and pain-related data, which was successfully exported and integrated into a research database. These findings suggest that OM-App may be a useful tool for remote monitoring of patients prescribed opioids for chronic pain. Clinical Trial: NCT03669939


 Citation

Please cite as:

Robinson-Papp J, Cedillo G, Deshpande R, George MC, Yang Q, Rogers J, Nmashie A, Mueller BR, Atreja A, Kummer B, Benn EK

Collecting patient reported outcomes to facilitate prescription opioid management: Development and testing of the Opioid Management App (OM-App)

JMIR Preprints. 18/08/2020:23633

DOI: 10.2196/preprints.23633

URL: https://preprints.jmir.org/preprint/23633

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.